Pittsburgh, PA, United States of America

Kenneth A Giuliano

USPTO Granted Patents = 13 


Average Co-Inventor Count = 2.8

ph-index = 9

Forward Citations = 732(Granted Patents)


Location History:

  • Pittsburg, PA (US) (2003)
  • Pittsburgh, PA (US) (1992 - 2013)

Company Filing History:


Years Active: 1992-2013

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Kenneth A. Giuliano

Introduction

Kenneth A. Giuliano is a prominent inventor based in Pittsburgh, PA (US), known for his significant contributions to the field of automated tissue analysis. With a total of 13 patents to his name, Giuliano has made strides in improving the methods used to identify and interpret tissue specimens, which has important implications for medical diagnostics and treatment.

Latest Patents

One of his latest patents is a method for automated tissue analysis. This invention provides an improved approach for identifying and interpreting tissue specimens and/or cells derived from these specimens. A panel of cell-based reagents offers various readouts of cellular states or biomarkers, which together define a profile of diverse cellular states in a tissue specimen. This profile represents the 'systems' nature of biology. The cellular profile is interpreted using informatics tools to identify similarities between specimens and in vivo medical conditions, ultimately suggesting options for treating medical conditions.

Career Highlights

Throughout his career, Kenneth A. Giuliano has worked with notable companies such as Cellomics, Inc. and Cernostics, Inc. His work in these organizations has contributed to advancements in the field of tissue analysis and diagnostics.

Collaborations

Giuliano has collaborated with esteemed colleagues, including Albert H. Gough and R. Terry Dunlay, further enhancing the impact of his work in the scientific community.

Conclusion

Kenneth A. Giuliano's innovative contributions to automated tissue analysis have paved the way for improved medical diagnostics and treatment options. His extensive patent portfolio and collaborations highlight his commitment to advancing the field of biomedical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…